SEARCH:   Advanced

Blood, Vol. 109, Issue 12, 5473-5476, June 15, 2007 This Article Abstract Full Text Services Email this article to a friend Alert me to new issues of the journal Rights and Permissions Citing Articles Citing Articles via CrossRef ERK1/2 phosphorylation is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia Blood Gregorj et al. 109: 5473 Supplemental materials for: Gregorj et al, Vol 109, Issue 12, 5473-5476 Files in this Data Supplement: Document 1. List of the institutions that provided samples for this study (PDF, 14.4 KB) Document 2. Supplemental materials and methods (PDF, 21.8 KB) Table S1. Cell cycle distribution in 131 ALL samples according to p-ERK1/2 expression (PDF, 11.9 KB) Table S2. Prognostic role of clinical and biological parameters (PDF, 13.2 KB) Figure S1. p-ERK1/2 expression in leukemia cell lines and in unstimulated and PMA-activated normal mononuclear cells (MNC) and in a representative leukemia primary sample (PDF, 43.1 KB) - Flow cytometric histograms showing fluorescence of irrelevant antibody (white) compared to p-ERK1/2 (black). Results were analyzed by the Kolmogorov-Smirnov statistic test. Data were confirmed by western blot analysis: blots were exposed to anti-p-ERK1/2 (upper line) and then probed with antibody to total ERK2 (lower line). This Article Abstract Full Text Services Email this article to a friend Alert me to new issues of the journal Rights and Permissions Citing Articles Citing Articles via CrossRef

	Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020